The CHK2 kinase is recurrently mutated and functionally impaired in the germline of pediatric cancer patientsRabea Wagener(Universität Ulm), Triantafyllia Brozou(Heinrich Heine University Düsseldorf)International Journal of CancerDecember 5, 202210.1002/ijc.34390Cited by 12SaveCiteExport RISWatch citationsRelated Papers<i>ATM</i> germ line pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignancies|Blood|2024|24